Sanjay Goel - Concepedia

Author

Sanjay Goel

Albert Einstein College of Medicine ORCID

Also Known As

Goel S, Goel, S., Goel, Sanjay, Goel, Shourya, S Goel, S. C. GOEL, S. C. Goel, S. GOEL, S. Goel, SANJAY GOEL

635

Publications

8.3K

Citations

H-Index

113

Concepts

All Affiliations

Albert Einstein College of Medicine Montefiore Medical Center University of Delhi The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute

About

Sanjay Goel is an author at Albert Einstein College of Medicine specializing in medicine, oncology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	51	2.3K
2	Engineering	5	5	63
3	Public Health	3	3	115
4	Health Sciences	2	2	36
5	Natural Sciences	2	2	48

Sanjay Goel

116

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System Vikas Mehta, Sanjay Goel, Rafi Kabarriti, Cancer Discovery	2020	796
Novel patterns of response under immunotherapy Édith Borcoman, Yada Kanjanapan, Stéphane Champiat, Annals of Oncology	2019	491
PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab Minaxi Jhawer, Sanjay Goel, Andrew J. Wilson, Cancer Research	2008	461
Seroconversion rates following COVID-19 vaccination among patients with cancer Astha Thakkar, Jesus D. Gonzalez‐Lugo, Niyati Goradia, Cancer Cell VaccinationCovid-19 PandemicVaccine EfficacyInfection ControlSeroconversion Rates	2021	362
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah, JAMA Oncology	2021	184
Apolipoprotein E suppresses glial cell secretion of TNFα Daniel T. Laskowitz, Sanjay Goel, Ellen Bennett Journal of Neuroimmunology InflammationSignal TransductionApolipoprotein ELipid PeroxidationApoptosis	1997	174
Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors R. Gollamudi, Mohammad H. Ghalib, Kavita Desai, Investigational New Drugs Viral ReplicationMolecular VirologyIntravenous AdministrationMedicinePathology	2009	150
A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies Sanjay Goel, Alain C. Mita, Monica Mita, Clinical Cancer Research	2009	144
Intratumoral Injection of <i>Clostridium novyi</i> -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors Filip Jankú, Halle Huihong Zhang, Abdulmohammad Pezeshki, Clinical Cancer Research	2020	139
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study Donna R. Rivera, Solange Peters, Orestis A. Panagiotou, Cancer Discovery	2020	138

Page 1